amniotide
Amniotide Inc. · a research lab

Foundation models for proteins and RNA.

We pretrain structure-native foundation models that read biological molecules as higher-dimensional objects, not as text. The result is a small set of general-purpose backbones, and many cheap task heads that ride on top of them.

message passing · illustrative
What we work on

Protein world model

A 105M-parameter structure-native backbone pretrained from scratch on every usable structure in the PDB. One frozen substrate; many small, fast-to-train heads for downstream tasks like mutation effect, stability, and design.

Architecture

RNA world model

A motif-aware, structure-native encoder for RNA, built in collaboration with academic structural-biology groups. Targets the long-range tertiary interactions that sequence-only models miss, like tetraloop receptors, kissing loops, and pseudoknots.

Architecture

For wet labs

Our backbones make a small seed of wet-lab data go further. In a recent benchmark, a fraction of one protein's deep mutational scan was enough to recover most of the predictive ceiling.

For labs
Recent result

ρ = 0.42 ρ = 0.62

Few-shot mutational-effect prediction on SRC kinase, held out from training. The protein backbone was frozen; only a small head was fine-tuned on a fraction of the assay.

Near-SOTA per-protein accuracy from roughly an order of magnitude less wet-lab data than a conventional fully supervised pipeline would require.

Assay
SRC_HUMAN_Ahler_2019
Support set
15% of mutations (505 labels)
Held-out test
85% of mutations (2,867 labels)
Backbone
Frozen, 105M parameters
Head trained
~3 min, single GPU
Implied data saving
85% reduction in DMS labels
Read the protocol
Working with us

For academic groups

We collaborate with structural-biology and protein-engineering labs. If you have an assay, a structure, or a folding problem we might be useful for, write to us. We share access to the backbones in exchange for a chance to publish jointly.

Get in touch
Working with us

For industry

We pilot with a small number of teams in pharma, antibody engineering, and enzyme design. Reach out about a per-target pilot or evaluation access to the demo.

Request access